RE:RE:Few QuestionsFrustrating for sure... he did say there is a queue of patients for when they decide to start. The smart thing is to do is to issue a press release on when the testing has started and revenue should rocket from there. I think we were expecting covid revenues to drop but he did mention a few more covid revenue streams to expect. There are still millions of antivaxxers out there who would prefer to pay for a test when travelling/concerts etc..than get the shot. I do agree with 1 year comment...mostly because he was preaching instant revenue with the rollout of Aristotle and decided to do it the long way too last minute. I do feel it is the best way to roll out Aristotle however he fked up with the lack of transparency which causes insecurity for an investor. I still feel the company still has huge potential and will slowly average down lol. Anyways GL ppl. #fukthebashers